@article {2037, title = {Nonmotoric Symptoms Scale (NMSS) Validity and Reliability Test in Patients with Parkinson{\textquoteright}s Disease in Dr. Soetomo General Hospital, Surabaya, Indonesia: A Questioner Validation Study}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {June 2023}, pages = {316-320}, type = {Original Article }, chapter = {316}, abstract = {

Background: Nonmotor symptoms are common but less reported in Parkinson{\textquoteright}s disease. it{\textquoteright}s the cause of decreased quality of life and disability in many patients with Parkinson{\textquoteright}s disease compared to the motor symptom. Our study aimed to translate the original English-language version of the nonmotor symptom scale (NMSS) into the Indonesian version of the NMSS. And also to evaluate its validity and reliability for use in Indonesian-speaking Parkinson{\textquoteright}s disease patients. This for better and valid usage of NMSS scale in the Indonesian patient and health care provider Material and Method: This was descriptive-analytic study. Cross-cultural adaptation of NMSS and psychometric analysis of the Indonesian version of NMSS was carried out from 2 Teaching Hospital centers in Surabaya, East Java. Several other scales were also examined, including MMSE, ESS, BDI, and Scopa-Aut. A reliability test was performed using Alpha Cronbach. Results: A total of 35 patients were included in this study. the average age was 64.03{\textpm}12.92 with the female sex 42.9\% (n=15) and the male 57.1\% (n=20), and Hoehn and Yahr stage II 57.1\% (n=20). The total average NMSS is 11.64. The validity of contents and constructs of the NMSS on each domain has been proven valid. Internal reliability of internal consistency in these tools with an alpha Cronbach value of 0.836. Each domain correlates with several other scores including MMSE, BDI, ESS, and Scopa-aut. Conclusion: The Indonesian version of NMSS has good validity and reliability in assessing nonmotor symptoms in Parkinson{\textquoteright}s disease patients in Indonesia.

}, keywords = {Nonmotoric Symptoms Scale, Parkinson{\textquoteright}s disease, Validation, Validity}, doi = {10.5530/pj.2023.15.81}, author = {Muhammad Hamdan and Priya Nugraha and Pramitha Nayana Librata and Cindy Cecilia} } @article {623, title = {High Performance Thin Layer Chromatographic Analysis for the Simultaneous Quantification of Two Polyphenolic Biomarkers in Methanolic Fraction of Bauhinia tomentosa L. Floral Buds}, journal = {Pharmacognosy Journal}, volume = {10}, year = {2018}, month = {May 2018}, pages = {773-777}, type = {Original Article}, chapter = {773}, abstract = {

Objectives: A high-performance thin layer chromatography (HPTLC) method for the simultaneous quantitative determination of caffeic acid and quercetin in methanolic fraction of Bauhinia tomentosa L. floral buds was developed for the first time. Method: For achieving good separation, a mobile phase of toluene: ethyl acetate: formic acid (7:3:0.5, v/v/v) was used. The densitometric determination was carried out at 366 nm in reflection/absorption mode. The calibration curves were linear in the range of 100-600 ng per spot for caffeic acid and quercetin. Results: During the analysis methanolic fraction of Bauhinia tomentosa L. floral buds showed the pres\¬ence of caffeic acid (0.02\%) and quercetin (0.018\%). Conclusion: The proposed method is simple, precise, specific, accurate, less time consuming and cost effective. The statistical analysis of data obtained proves that the method is reproducible and selective and can be used for routine analysis of reported phenolic compounds in crude drug and extracts. The simultaneous quan\¬tification of these compounds has not yet been reported in floral buds of Bauhinia tomentosa which may be utilized for the proper standardization of the plant.

}, keywords = {Bauhinia tomentosa, Caffeic acid, HPTLC, Quercetin, Validation}, doi = {10.5530/pj.2018.4.130}, url = {http://fulltxt.org/article/668}, author = {Abhishek Gupta and Harinath Dwivedi and AKS Rawat} } @article {609, title = {Renin and Angiotensin Converting Enzyme Inhibition of Standardized Bioactive Fractions of Hyphaene thebaica L. Mart Growing in Egypt}, journal = {Pharmacognosy Journal}, volume = {10}, year = {2018}, month = {June 2018}, pages = {622-627}, type = {Original Article}, chapter = {622}, abstract = {

Introduction: Hyphaene thebaica L. fruit is known in Egypt for its antihypertensive activity. However a standardized herbal extract/fraction was never prepared. Methods: A biologically guided fractionation was carried out in-vitro for the 50\% and 70\% ethanol extracts of Hyphaene thebaica L. fruit using the angiotensin converting enzyme (ACE) inhibition and renin inhibition assays. A validated reversed phase HPLC method was developed for the standardization of the active fractions. Results: The ethyl acetate fraction of the 70\% extract contained higher percentages of the three bioactive markers chlorogenic acid, quercetin and apigenin (1.940 \± 0.140\%, 2.994 \± 0.349\% and 0.612 \± 0.0354\%, respectively) relative to the ethyl acetate fraction of the 50\% extract (1.384 \± 0.157\%, 0.342 \± 0.0834\% and 0.070 \± 0.00225\%, respectively). The butanol fraction of the 70\% extract was found to possess the highest antihypertensive activity (93.69 \± 5.695 \% renin inhibition activity at 0.5 mg/mL and IC50 of 0.001436 +0.00044 mg/mL for ACE inhibition activity). A standard calibration curve for the three compounds was established at a concentration range of 0.1-50 \μg/Ml, they showed good linearity with a correlation coefficient (R2) of (1.00, 1.00 and 0.999; respectively). A high degree of precision (relative standard deviation values \<5\%) was achieved. The limits of detection for the three compounds were 0.428, 0.368 and 0.849; respectively, while the limits of quantitation were 1.29, 1.11 and 2.57, respectively. Conclusions: Current results showed that the butanol fraction of the 70\% extract revealed the highest antihypertensive activity through ACE and renin inhibition mechanisms. In addition, recorded observations concerning linearity of the used bioactive markers offer a support for the possible utility of the tested fractions as potent standardized antihypertensive drugs.

}, keywords = {Antihypertensive, Doum, HPLC, Phenolics, standardization, Validation}, doi = {10.5530/pj.2018.4.102}, url = {http://fulltxt.org/article/640}, author = {Noha A Khalil and Amira Abdel Motaal and Khaled Meselhy and Soad M Abdel khalek} } @article {128, title = {Validated analytical RP-HPLC method for quantitation of wedelolactone from Eclipta alba and marketed Ayurvedic formulations}, journal = {Pharmacognosy Journal}, volume = {8}, year = {2016}, month = {December 2015}, pages = {132-139}, type = {Original Article}, chapter = {132}, abstract = {

Introduction: Eclipta alba Linn. (Asteraceae) is an important ingredient of several Ayurvedic formulations. The monograph on different parts of plant like flowers, leaves, roots are listed in Ayurvedic pharmacopeia of India. The plant is reported to be effective for broad range maladies like inflammation, reproductive problems of females etc. It is also used as a hepatoprotectant, analgesic, antibacterial and antidiabetic agent. Wedelolactone is used as a bioactive marker to establish the quality of the crude drug and its formulations. In the present study, wedelolactone-based standardization of Eclipta alba and its quantitation from marketed herbal and Ayurvedic formulations has been documented using RP-HPLC. Methods: In the current work, an isocratic method has been developed and validated to quantitate wedelolactone from whole plant of Eclipta alba. This method is validated as per ICH guidelines and is used to quantitate the content of wedelolactone in polyherbal formulations like Liv52, Geriforte, Mahabhringaraj oil etc. Results: The LOD is found to be 0.5 \μg/mL and the LOQ is 1 \μg/mL. The linearity range of response is from 5 \μg/mL to 100 \μg/mL. Conclusion: The validated method is found to be simple, sensitive, accurate, rugged and reproducible. This developed method can be recommended for quality assurance and marker-based standardization of polyherbal formulations containing whole plant of Eclipta alba.

}, keywords = {Eclipta alba, Formulations, RP-HPLC, Validation, Wedelolactone., Whole plant}, doi = {10.5530/pj.2016.2.6}, author = {Sunita Shailajan and Sasikumar Menon and Dipti Singh and Gauri Swar} } @article {1506, title = {Antihyperglycemic Activity and Standardization of the Bioactive Extract of Cleome droserifolia Growing in Egypt}, journal = {Pharmacognosy Journal}, volume = {6}, year = {2014}, month = {2nd July 2014}, pages = {15-21}, type = {Original Article}, abstract = {

Background:Cleome droserifolia herb is well known in the Egyptian folk medicine for the treatment of diabetes. However, a standardized active extract of the herb was never prepared for incorporation into a pharmaceutical dosage form. Materials and Methods: Comparative high performance liquid chromatography (HPLC) chromatographic profi les were established in order to study the ethnopharmacological use of the antihyperglycemic herb using a validated reversed phase- HPLC method which was developed for standardization of the active aqueous extract. A biologically guided fractionation of the antihyperglycemic aqueous extract was carried out in vivo using alloxan induced diabetic rats. Results: The aqueous extract contained the highest percent of the total active fl avonol glycosides (78.20\%) compared to the 70\% and 50\% ethanolic extracts (51.17 and 42.66\%, respectively). The aqueous extract and its ethyl acetate fraction possessed the highest antihyperglycemic activities. A standard calibration curve, established for the major bioactive methoxylated fl avonol glycoside (kaempferol-4\’-methoxy-3,7-dirhamnoside) at a concentration range of 44-174 \μg/ml, showed good linearity with a correlation coeffi cient (R2) of 0.998. The recovery of the method was 100.5\%. A high degree of precision (relative standard deviation values \<5\%) was achieved. The limits of detection and quantifi cation were 0.01 and 0.02 \μg/ml, respectively, indicating the sensitivity of the method. Conclusion: The aqueous extract contained the highest percent of the total active fl avonol glycosides. The extract, standardized to contain not \<1.5 \± 0.06\% of kaempferol-4\’-methoxy- 3,7-dirhamnoside, was tested at three different dose levels showing a 63.3\% activity of that of metformin at100 mg/kg body weight. Furthermore, it raised the blood insulin level by 146.26\% at this dose level.

Key words: Antihyperglycemic, Cleome droserifolia, high performance liquid chromatography standardization, kaempferol-4\’-methoxy-3,7-dirhamnoside, validation.

}, keywords = {7-dirhamnoside, Antihyperglycemic, Cleome droserifolia, high performance liquid chromatography standardization, kaempferol-4{\textquoteright}-methoxy-3, Validation}, author = {Amira Abdel Motaal and Shahira M. Ezzat and Hesham El-Askary} }